Profound Medical (TSX:PRN) Cyclically Adjusted FCF per Share: C$-2.18 (As of Mar. 2026)


TSX:PRN Profound Medical Corp TSX:PRN
66 GF Score
Price C$10.05
GF Value C$20.38
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Profound Medical Cyclically Adjusted FCF per Share?

Profound Medical TSX:PRN -4.10% 66 Cyclically Adjusted FCF per Share is C$-2.18 as of Mar. 2026. GuruFocus rates TSX:PRN with a GF Score™ of 66/100 and a GF Value™ of C$20.38 (Possible Value Trap). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Profound Medical's adjusted free cash flow per share for the three months ended in Mar. 2026 was C$-0.324. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is C$-2.18 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-10), Profound Medical's current stock price is C$10.05. Profound Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was C$-2.18. Profound Medical's Cyclically Adjusted Price-to-FCF of today is .


Profound Medical  (TSX:PRN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Profound Medical Cyclically Adjusted FCF per Share Related Terms


Profound Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Profound Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profound Medical Cyclically Adjusted FCF per Share Chart

Profound Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.48 -2.23

Profound Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.47 -2.26 -2.25 -2.23 -2.18

TSX:PRN vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Profound Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profound Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Profound Medical's Cyclically Adjusted Price-to-FCF falls into.


TSX:PRN
66GF Score
Profound Medical Corp TSX:PRN
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Profound Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Profound Medical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.324/132.2623*132.2623
=-0.324

Current CPI (Mar. 2026) = 132.2623.

Profound Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -1.010 102.002 -1.310
201609 -0.825 101.765 -1.072
201612 -0.970 101.449 -1.265
201703 -0.713 102.634 -0.919
201706 -0.810 103.029 -1.040
201709 -0.463 103.345 -0.593
201712 -0.617 103.345 -0.790
201803 -0.482 105.004 -0.607
201806 -0.495 105.557 -0.620
201809 -0.462 105.636 -0.578
201812 -0.330 105.399 -0.414
201903 -0.298 106.979 -0.368
201906 -0.594 107.690 -0.730
201909 -0.297 107.611 -0.365
201912 -0.595 107.769 -0.730
202003 -0.684 107.927 -0.838
202006 -0.139 108.401 -0.170
202009 -0.304 108.164 -0.372
202012 -0.484 108.559 -0.590
202103 -0.400 110.298 -0.480
202106 -0.371 111.720 -0.439
202109 -0.319 112.905 -0.374
202112 -0.319 113.774 -0.371
202203 -0.479 117.646 -0.539
202206 -0.343 120.806 -0.376
202209 -0.369 120.648 -0.405
202212 -0.430 120.964 -0.470
202303 -0.385 122.702 -0.415
202306 -0.298 124.203 -0.317
202309 -0.284 125.230 -0.300
202312 -0.472 125.072 -0.499
202403 -0.252 126.258 -0.264
202406 -0.349 127.522 -0.362
202409 -0.377 127.285 -0.392
202412 -0.325 127.364 -0.337
202503 -0.396 129.181 -0.405
202506 -0.625 129.892 -0.636
202509 -0.442 130.287 -0.449
202512 -0.296 130.366 -0.300
202603 -0.324 132.262 -0.324

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of C$-2.18 mean?
Profound Medical (TSX:PRN) has a Cyclically Adjusted FCF per Share of C$-2.18 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Profound Medical and its competitors.
Is Profound Medical's Cyclically Adjusted FCF per Share too high?
Profound Medical's current Cyclically Adjusted FCF per Share is C$-2.18. Overall, Profound Medical has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Profound Medical's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Profound Medical's Cyclically Adjusted FCF per Share of C$-2.18 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Profound Medical and its competitors. Profound Medical's current Cyclically Adjusted FCF per Share is C$-2.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profound Medical stock overvalued right now?
Based on GuruFocus' analysis, Profound Medical (TSX:PRN) is currently considered Possible Value Trap. The stock's GF Value™ is C$20.38, compared to a current price of C$10.05 — trading 50.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is C$-2.18. Profound Medical's overall GF Score™ is 66/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Profound Medical (TSX:PRN), the current Cyclically Adjusted FCF per Share is C$-2.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Profound Medical (TSX:PRN) Overvalued in 2026?

Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued. The current stock price of C$10.05 is trading 50.7% below its estimated GF Value™ of C$20.38. GuruFocus considers Profound Medical to be Possible Value Trap.

Key valuation signals for TSX:PRN:

  • Cyclically Adjusted FCF per Share: C$-2.18
  • GF Value™: C$20.38 vs. price of C$10.05 (50.7% below fair value)
  • GF Score™: 66/100 with 1 warning sign

No single metric tells the full story. See the TSX:PRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Profound Medical Business Description

Other Exchanges PROF:USA
Address 2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
66GF Score

Get the complete analysis for TSX:PRN

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$10.05
Price
C$20.38
GF Value